CoreMap is a medical technology company specializing in advanced diagnostic solutions for atrial fibrillation (AF), a common heart arrhythmia. Founded in 2016 and headquartered in Vermont and Massachusetts, CoreMap aims to revolutionize the treatment of AF by providing physicians with high-resolution mapping tools that enable patient-specific treatments. The company's investigational devices are designed to offer precise diagnostics, which can lead to more effective and individualized treatment plans for patients suffering from persistent and complex atrial arrhythmias. CoreMap primarily serves healthcare providers and cardiologists who treat AF patients, operating within the medical technology and healthcare sectors. The business model focuses on the development and commercialization of its proprietary diagnostic technology, generating revenue through the sale and licensing of its devices.

Keywords: atrial fibrillation, diagnostic technology, patient-specific treatment, medical technology, healthcare, arrhythmia, high-resolution mapping, investigational device, cardiology, advanced diagnostics.